Brief: Genetic Signatures Says Decision To Cease Development Of US Respiratory Product
27/05/2024 02:31
May 27 (Reuters) - Genetic Signatures Ltd GSS.AX :
* DECISION TO CEASE DEVELOPMENT OF US RESPIRATORY PRODUCT
Source text for Eikon: ID:nASX1mZq6q
Further company coverage: GSS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes